175 related articles for article (PubMed ID: 20669226)
21. Predictors of survival following surgical resection of thymoma.
McCart JA; Gaspar L; Inculet R; Casson AG
J Surg Oncol; 1993 Dec; 54(4):233-8. PubMed ID: 8255084
[TBL] [Abstract][Full Text] [Related]
22. Assessment of multimodality therapy for thymoma.
Chen J; Wang P
Chin Med J (Engl); 2010 May; 123(10):1295-8. PubMed ID: 20529584
[TBL] [Abstract][Full Text] [Related]
23. A tale of autoimmunity: thymoma, thymectomy, and systemic lupus erythematosus.
Mollaeian A; Haas C
Clin Rheumatol; 2020 Jul; 39(7):2227-2234. PubMed ID: 32277368
[TBL] [Abstract][Full Text] [Related]
24. Thymoma. Analysis of prognostic factors.
Sonobe M; Nakagawa M; Ichinose M; Ikegami N; Nagasawa M; Shindo T
Jpn J Thorac Cardiovasc Surg; 2001 Jan; 49(1):35-41. PubMed ID: 11233240
[TBL] [Abstract][Full Text] [Related]
25. Myasthenia gravis with thymoma is not associated with an increased incidence of non-muscle autoimmune disorders.
Aarli JA; Gilhus NE; Matre R
Autoimmunity; 1992; 11(3):159-62. PubMed ID: 1571478
[TBL] [Abstract][Full Text] [Related]
26. CXCR4 overexpression correlates with poor prognosis in myasthenia gravis-associated thymoma.
Wang W; Liu D; Yang L; Li Y; Xu H; Wang F; Zhao J; Zhang L
Hum Pathol; 2016 Mar; 49():49-53. PubMed ID: 26826409
[TBL] [Abstract][Full Text] [Related]
27. Thymoma with dissemination: efficacy of macroscopic total resection of disseminated nodules.
Yano M; Sasaki H; Yukiue H; Kawano O; Okuda K; Hikosaka Y; Fujii Y
World J Surg; 2009 Jul; 33(7):1425-31. PubMed ID: 19424745
[TBL] [Abstract][Full Text] [Related]
28. Surgical resection of thymoma still represents the first choice of treatment.
Ried M; Guth H; Potzger T; Diez C; Neu R; Schalke B; Hofmann HS
Thorac Cardiovasc Surg; 2012 Mar; 60(2):145-9. PubMed ID: 21692020
[TBL] [Abstract][Full Text] [Related]
29. [Thymoma and autoimmune diseases].
Jamilloux Y; Frih H; Bernard C; Broussolle C; Petiot P; Girard N; Sève P
Rev Med Interne; 2018 Jan; 39(1):17-26. PubMed ID: 28365191
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors for survival in advanced thymomas: The role of the number of involved structures.
Chiappetta M; Aprile V; Lococo F; Zanfrini E; Nachira D; Meacci E; Korasidis S; Ambrogi M; Lucchi M; Margaritora S
J Surg Oncol; 2021 Oct; 124(5):858-866. PubMed ID: 34252198
[TBL] [Abstract][Full Text] [Related]
31. Increased risk of hepatobiliary cancers after hospitalization for autoimmune disease.
Castro FA; Liu X; Försti A; Ji J; Sundquist J; Sundquist K; Koshiol J; Hemminki K
Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1038-45.e7. PubMed ID: 24246767
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcomes after thoracoscopic resection of stage I and II thymoma: a propensity-matched study.
Chao YK; Liu YH; Hsieh MJ; Wu YC; Chen TP; Lu MS; Lu HI; Liu HP
Ann Surg Oncol; 2015 Apr; 22(4):1371-6. PubMed ID: 25256127
[TBL] [Abstract][Full Text] [Related]
33. Thymomas in patients with myasthenia gravis.
Slater G; Papatestas AE; Genkins G; Kornfeld P; Horowitz SH; Bender A
Ann Surg; 1978 Aug; 188(2):171-4. PubMed ID: 686883
[TBL] [Abstract][Full Text] [Related]
34. Multidisciplinary treated thymomas with fatal outcome. A retrospective study.
Ionescu L; Dănilă R; Timofte D; Butcovan D; Stefanescu C
Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):675-8. PubMed ID: 25341283
[TBL] [Abstract][Full Text] [Related]
35. Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden.
Wassberg C; Thörn M; Yuen J; Ringborg U; Hakulinen T
Br J Cancer; 1996 Jan; 73(2):255-9. PubMed ID: 8546916
[TBL] [Abstract][Full Text] [Related]
36. Thymoma. Histologic subclassification is an independent prognostic factor.
Quintanilla-Martinez L; Wilkins EW; Choi N; Efird J; Hug E; Harris NL
Cancer; 1994 Jul; 74(2):606-17. PubMed ID: 8033040
[TBL] [Abstract][Full Text] [Related]
37. Clinical and pathologic predictors of survival in patients with thymic tumors.
Lequaglie C; Giudice G; Brega Massone PP; Conti B; Cataldo I
J Cardiovasc Surg (Torino); 2002 Apr; 43(2):269-74. PubMed ID: 11887069
[TBL] [Abstract][Full Text] [Related]
38. Outcome in excised thymomas: role of prognostic factors and impact of additional malignancies on survival.
Granato F; Blackhall V; Alessandra R; Spina D; Luca V; Piero P; Mohiyaddin S; Asif M; Kirk AJ; Giuseppe G
Scott Med J; 2014 Feb; 59(1):22-9. PubMed ID: 24463694
[TBL] [Abstract][Full Text] [Related]
39. Clinical and pathologic predictors of outcome in thymoma-associated myasthenia gravis.
López-Cano M; Ponseti-Bosch JM; Espin-Basany E; Sánchez-García JL; Armengol-Carrasco M
Ann Thorac Surg; 2003 Nov; 76(5):1643-9; discussion 1649. PubMed ID: 14602301
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis, treatment and prognosis of thymoma: an analysis of 116 cases.
Wang Y; Sun Y; Zhang J; Zhou N; Liu Y; Li X; Xu Y
Chin Med J (Engl); 2003 Aug; 116(8):1187-90. PubMed ID: 12935408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
